
In a groundbreaking partnership, Absci and AstraZeneca have joined hands to harness the power of artificial intelligence (AI) in the quest for a novel cancer treatment. This collaboration marks a significant milestone in the field of drug discovery, showcasing the potential of AI in revolutionizing the way we combat cancer. Integration of Absci’s Integrated Drug Creation Platform with AstraZeneca’s Oncology









